These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 19305027)

  • 61. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia].
    Chen H; Ren HY; Guo NL; Huang XJ; Liu KY; Xu LP; Zhang YC; Zheng H; Wu T; Liu DH; Yang SM; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):87-90. PubMed ID: 14990046
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
    Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
    Guièze R; Cornillet-Lefebvre P; Lioure B; Blanchet O; Pigneux A; Recher C; Bonmati C; Fegueux N; Bulabois CE; Bouscary D; Vey N; Delain M; Turlure P; Himberlin C; Harousseau JL; Dreyfus F; Béné MC; Ifrah N; Chevallier P;
    Am J Hematol; 2012 Dec; 87(12):1052-6. PubMed ID: 22911473
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A clinical study of allo-hematopoietic stem cell transplantation in HBsAg positive leukemia].
    Chen Y; Xu LP; Liu KY; Liu DH; Han W; Chen H; Zhang YC; Chen YH; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):316-9. PubMed ID: 18843958
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Haemopoietic cell transplantation activity and results: a single institution experience.
    Barta A; Batai A; Torbagyi E; Sipos A; Lengyel L; Petranyi GG; Paloczi K; Kelemen E
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S60-2. PubMed ID: 9916638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
    Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
    Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
    Devillier R; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Harbi S; Granata A; D'Incan E; Coso D; Chabannon C; Picard C; Etienne A; Calmels B; Schiano JM; Lemarie C; Stoppa AM; Bouabdallah R; Vey N; Blaise D
    Am J Hematol; 2014 Jan; 89(1):83-7. PubMed ID: 24108528
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party.
    Wachowiak J; Sykora KW; Cornish J; Chybicka A; Kowalczyk JR; Gorczyńska E; Choma M; Grund G; Peters C;
    Bone Marrow Transplant; 2011 Dec; 46(12):1510-8. PubMed ID: 21297673
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
    Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Outcome analysis of alternative donor allogeneic hematopoietic cell transplantation in the treatment of 19 severe aplastic anemia patients].
    Chen X; Wei J; Huang Y; He Y; Yang D; Jiang E; Ma Q; Yao J; Zhou L; Lin X; Shen Y; Yang X; Wang Z; Feng S; Han M
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):9-12. PubMed ID: 24602723
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Allogeneic hematopoietic stem cell transplantation for acute leukemias of ambiguous lineage in adults: a comparison between the conditioning of different intensities].
    Zhang Y; Chen YK; Liu QF; Fan ZP; Jiang QL; Zhao J; Wei Q; Li XF; Yu GP; Sun J; Chai YY
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1379-83. PubMed ID: 21756807
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [High-dose therapy followed by auto HSCT in children--with advanced neuroblastoma in four transplant centres in Poland].
    Zaucha-Prazmo A; Drabko K; Wójcik B; Choma M; Kałwak K; Gorczyńska E; Turkiewicz D; Słociak M; Ussowicz M; Dyla A; Chybicka A; Goździk J; Ratajczak M; Styczyński J; Debski R; Wysocki M; Kowalczyk J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):775-84. PubMed ID: 17317908
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
    Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hematopoietic stem cell transplantation in infants.
    Gassas A; Ashraf K; Zaidman I; Ali M; Krueger J; Doyle J; Schechter T; Leucht S
    Pediatr Blood Cancer; 2015 Mar; 62(3):517-21. PubMed ID: 25393821
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Allogeneic hematopoietic stem cell transplantation from HLA-matched donor for 14 patients with myelodysplastic syndrome].
    Zhou Y; Huang WR; Li HH; Gao CJ; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):731-4. PubMed ID: 20561439
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.
    Bizzarri C; Pinto RM; Ciccone S; Brescia LP; Locatelli F; Cappa M
    Pediatr Blood Cancer; 2015 Sep; 62(9):1650-5. PubMed ID: 26017459
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation.
    Kato M; Hasegawa D; Koh K; Kato K; Takita J; Inagaki J; Yabe H; Goto H; Adachi S; Hayakawa A; Takeshita Y; Sawada A; Atsuta Y; Kato K
    Br J Haematol; 2015 Feb; 168(4):564-70. PubMed ID: 25302748
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation.
    Chevallier P; Prebet T; Turlure P; Hunault M; Vigouroux S; Harousseau JL; Blaise D; Ifrah N; Milpied N; Mohty M
    Bone Marrow Transplant; 2010 Jan; 45(1):165-70. PubMed ID: 19584826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.